Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma
Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma
Recruiting · NCT06767306 · Registry updated 2026-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma | Melanoma Metastatic | Recruiting | Phase 2 | 2026-05-07 | NCT06767306 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Melanoma Institute Australia | 11 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Melanoma Institute Australia | Wollstonecraft | Australia | 19 |
| Princess Alexandra Hospital | Woolloongabba | Australia | 106 |
| Princess Margaret Cancer Centre | Toronto | Canada | 9 |
| The Alfred Hospital | Melbourne | Australia | 110 |
| Westmead Hospital | Westmead | Australia | 128 |